You
SI

Scinai Immunotherapeutics Ltd.

Company · Health · L3
Statements1
Sightings1
Years covered2025 – now
Primary sourceSEC Form 20-F
All statements
2025 – nowCurrentOur mission is to deliver high-quality, flexible, and cost-effective CDMO services in a “boutique” style, catering to early-stage biotech companies.Mission · Craft & quality · SEC Form 20-F, filed 2025-05-07
Organization
Type
Company
Industry
Health
Location
L3, US
Size
—
Website
—
Status
active
All filings on SEC EDGAR ↗